Teladoc Health (NYSE:TDOC) Insider Fernando Rodrigues Sells 4,209 Shares

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 4,209 shares of the business’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Teladoc Health Price Performance

NYSE TDOC opened at $7.39 on Thursday. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The stock has a market cap of $1.31 billion, a price-to-earnings ratio of -5.82 and a beta of 2.04. The company’s 50 day moving average is $8.02 and its two-hundred day moving average is $7.76.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.05. The firm had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The company’s revenue was down 2.2% on a year-over-year basis. During the same period last year, the firm earned ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

TDOC has been the subject of several research analyst reports. Evercore ISI cut their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a report on Thursday, October 30th. Zacks Research cut shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. BMO Capital Markets began coverage on shares of Teladoc Health in a research note on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday. Finally, Bank of America reduced their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a report on Tuesday, November 25th. Five research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $9.68.

Institutional Investors Weigh In On Teladoc Health

Several large investors have recently added to or reduced their stakes in TDOC. Y Intercept Hong Kong Ltd bought a new stake in Teladoc Health during the 2nd quarter valued at $2,722,000. Farther Finance Advisors LLC raised its holdings in shares of Teladoc Health by 424.5% in the second quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock valued at $87,000 after acquiring an additional 8,061 shares in the last quarter. American Century Companies Inc. raised its holdings in shares of Teladoc Health by 78.8% in the first quarter. American Century Companies Inc. now owns 375,050 shares of the health services provider’s stock valued at $2,985,000 after acquiring an additional 165,332 shares in the last quarter. Invenomic Capital Management LP lifted its stake in Teladoc Health by 36.3% in the first quarter. Invenomic Capital Management LP now owns 1,327,128 shares of the health services provider’s stock worth $10,564,000 after acquiring an additional 353,478 shares during the period. Finally, Vanguard Group Inc. grew its holdings in Teladoc Health by 7.0% during the 1st quarter. Vanguard Group Inc. now owns 19,752,338 shares of the health services provider’s stock worth $157,229,000 after acquiring an additional 1,289,183 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.